Milestone Pharmaceuticals Inc.
MIST- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001408443
No open-market purchases or sales by Milestone Pharmaceuticals Inc. insiders were filed in the last 90 days; 78 institutions reported holding it in 13F filings for Q2 2026, worth $66.4M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Milestone Pharmaceuticals Inc. as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −6 vs. Q1 2021
- Shares held
- 20.1M
- −136.2K (−0.7%) vs. Q1 2021
- Total value
- $110.8M
- −$6.63M (−5.6%) vs. Q1 2021
- New holders
- 2
- 8 more added
- Sold out
- 8
- 8 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MIST on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 78 | $66.4M |
| Q1 2026 | 87 | $47.2M |
| Q4 2025 | 80 | $70.7M |
| Q3 2025 | 61 | $68.3M |
| Q2 2025 | 43 | $22.9M |
| Q1 2025 | 43 | $9.46M |
| Q4 2024 | 47 | $57.9M |
| Q3 2024 | 43 | $43.6M |
| Q2 2024 | 40 | $39.9M |
| Q1 2024 | 43 | $56.4M |
| Q4 2023 | 40 | $29.7M |
| Q3 2023 | 39 | $60.7M |
| Q2 2023 | 48 | $59.0M |
| Q1 2023 | 50 | $85.5M |
| Q4 2022 | 56 | $96.9M |
| Q3 2022 | 47 | $198.7M |
| Q2 2022 | 29 | $127.2M |
| Q1 2022 | 28 | $135.1M |
| Q4 2021 | 28 | $132.6M |
| Q3 2021 | 27 | $113.9M |
| Q2 2021 | 28 | $110.8M |
| Q1 2021 | 34 | $117.4M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Milestone Pharmaceuticals Inc.; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Carroll Financial Associates, Inc. | 40 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 199 | $1.00K | 0.00% | −104−34.3% | Reduced |
| Proequities, Inc. | 245 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 483 | $3.00K | 0.00% | −13,016−96.4% | Reduced |
| Advisor Group Holdings, Inc. | 1,472 | $8.00K | 0.00% | +871+144.9% | Added |
| Tower Research Capital LLC (TRC) | 1,566 | $9.00K | 0.00% | +1,566 | New |
| Federation des caisses Desjardins du Quebec | 10,500 | $57.8K | 0.00% | −100−0.9% | Reduced |
| Goldman Sachs Group Inc | 12,004 | $66.0K | 0.00% | 00.0% | Unchanged |
| Acadian Asset Management LLC | 12,069 | $67.0K | 0.00% | +12,069 | New |
| Two Sigma Investments, LP | 16,235 | $89.0K | 0.00% | −38,578−70.4% | Reduced |
| State Street Corp | 16,626 | $91.0K | 0.00% | −390−2.3% | Reduced |
| Geode Capital Management, LLC | 20,859 | $114.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 35,600 | $196.0K | 0.00% | −22,500−38.7% | Reduced |
| Dimensional Fund Advisors LP | 47,200 | $260.0K | 0.00% | +8,884+23.2% | Added |
| Susquehanna Fundamental Investments, LLC | 51,502 | $283.0K | 0.01% | −9,135−15.1% | Reduced |
| Renaissance Technologies LLC | 107,554 | $592.0K | 0.00% | −108,846−50.3% | Reduced |
| Barclays PLC | 203,901 | $1.12M | 0.00% | +47,025+30.0% | Added |
| Boothbay Fund Management, LLC | 224,758 | $1.24M | 0.05% | +16,426+7.9% | Added |
| Pura Vida Investments, LLC | 702,545 | $3.86M | 0.28% | +234,905+50.2% | Added |
| Millennium Management LLC | 718,630 | $3.95M | 0.01% | +833+0.1% | Added |
| Suvretta Capital Management, LLC | 851,291 | $4.68M | 0.07% | 00.0% | Unchanged |
| Morgan Stanley | 885,199 | $4.87M | 0.00% | +34,157+4.0% | Added |
| Ikarian Capital, LLC | 1,980,400 | $10.9M | 1.95% | +143,855+7.8% | Added |
| Ra Capital Management, L.P. | 2,246,503 | $12.4M | 0.20% | 00.0% | Unchanged |
| Novo Holdings A/S | 2,530,585 | $13.9M | 0.62% | 00.0% | Unchanged |
| Boxer Capital, LLC | 2,572,194 | $14.1M | 0.50% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 2,583,821 | $14.2M | 0.15% | 00.0% | Unchanged |
| RTW Investments, LP | 4,315,102 | $23.7M | 0.36% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −267,997−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −100,283−100.0% | Sold out |
| California Public Employees Retirement System | 0 | $0 | 0.00% | −50,100−100.0% | Sold out |
| TD Asset Management Inc | 0 | $0 | 0.00% | −18,704−100.0% | Sold out |
| Cowen and Company, LLC | 0 | $0 | 0.00% | −5,166−100.0% | Sold out |
| Sowell Financial Services LLC | 0 | $0 | 0.00% | −1,440−100.0% | Sold out |
| Wealthcare Advisory Partners LLC | 0 | $0 | 0.00% | −352−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −37−100.0% | Sold out |